David Wylie

572 total citations
13 papers, 487 citations indexed

About

David Wylie is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Wylie has authored 13 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Wylie's work include Protein purification and stability (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virus-based gene therapy research (2 papers). David Wylie is often cited by papers focused on Protein purification and stability (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virus-based gene therapy research (2 papers). David Wylie collaborates with scholars based in United States, Switzerland and Greece. David Wylie's co-authors include Ann Stock, Jeff Stock, Susan Cannon‐Carlson, Marcio Voloch, Yan‐Hui Liu, Collette Cutler, James Mottonen, Elizabeth B. Gottlin, Clarence E. Schutt and Alexander J. Ninfa and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

David Wylie

13 papers receiving 459 citations

Peers

David Wylie
Constance L. Fisher United States
Anne B. Neef Switzerland
Shalom D. Goldberg United States
O.W. Odom United States
R E Brissette United States
Kittichoat Tiyanont United States
Chris Jeans United States
Eran Or Israel
Constance L. Fisher United States
David Wylie
Citations per year, relative to David Wylie David Wylie (= 1×) peers Constance L. Fisher

Countries citing papers authored by David Wylie

Since Specialization
Citations

This map shows the geographic impact of David Wylie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wylie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wylie more than expected).

Fields of papers citing papers by David Wylie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wylie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wylie. The network helps show where David Wylie may publish in the future.

Co-authorship network of co-authors of David Wylie

This figure shows the co-authorship network connecting the top 25 collaborators of David Wylie. A scholar is included among the top collaborators of David Wylie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wylie. David Wylie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gao, Xinliu, Yi Wang, Xuanwen Li, et al.. (2019). Targeted Host Cell Protein Quantification by LC–MRM Enables Biologics Processing and Product Characterization. Analytical Chemistry. 92(1). 1007–1015. 37 indexed citations
2.
Liu, Yan‐Hui, David Wylie, Jia Zhao, et al.. (2010). Mass spectrometric characterization of the isoforms in Escherichia coli recombinant DNA-derived interferon alpha-2b. Analytical Biochemistry. 408(1). 105–117. 11 indexed citations
3.
Wylie, David, et al.. (2005). Characterization of Interferon a2B Pegylated via Carboxyalkylation: A Case Study. Humana Press eBooks. 308. 337–348. 4 indexed citations
4.
Grace, Michael J., Sheri Bradshaw, Stuart Cox, et al.. (2005). Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-α Antiviral and Antiproliferative Activities through the JAK/STAT Signaling Pathway. Journal of Biological Chemistry. 280(8). 6327–6336. 72 indexed citations
5.
Cannon‐Carlson, Susan, et al.. (2005). CMC and regulatory considerations for polyethylene glycol-modified protein therapeutics. Drug Delivery System. 20(6). 620–634. 2 indexed citations
6.
Deng, Liang, et al.. (2004). Detection and quantification of the human IgG4 half‐molecule, HL, from unpurified cell‐culture supernatants. Biotechnology and Applied Biochemistry. 40(3). 261–269. 9 indexed citations
7.
Liu, Yan‐Hui, Guodong Chen, Urooj A. Mirza, et al.. (2003). Proteomic study of recombinant adenovirus 5 encoding human p53 by matrix-assisted laser desorption/ionization mass spectrometry in combination with database search. International Journal of Mass Spectrometry. 226(1). 55–69. 11 indexed citations
8.
Wylie, David, et al.. (2001). Carboxyalkylated Histidine Is a pH-Dependent Product of Pegylation with SC-PEG. Pharmaceutical Research. 18(9). 1354–1360. 36 indexed citations
9.
Porter, Frederick, Suganto Sutjipto, Collette Cutler, et al.. (2001). Empty Capsids in Column-Purified Recombinant Adenovirus Preparations. Human Gene Therapy. 12(15). 1923–1936. 60 indexed citations
10.
Tsarbopoulos, Anthony, Susan Cannon‐Carlson, David Wylie, et al.. (2000). Mass spectrometric mapping of disulfide bonds in recombinant human interleukin-13. Journal of Mass Spectrometry. 35(3). 446–453. 8 indexed citations
11.
Stock, Ann, David Wylie, James Mottonen, et al.. (1988). Phosphoproteins Involved in Bacterial Signal Transduction. Cold Spring Harbor Symposia on Quantitative Biology. 53(0). 49–57. 66 indexed citations
12.
Wylie, David, et al.. (1988). Sensory transduction in bacterial chemotaxis involves phosphotransfer between CHE proteins. Biochemical and Biophysical Research Communications. 151(2). 891–896. 166 indexed citations
13.
Wylie, David & Thomas Vanaman. (1987). [5] Purification and characterization of Acanthamoeba calcium-binding proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 139. 50–68. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026